WAM
TMDX icon

Wakefield Asset Management’s Transmedics TMDX Stock Holding History

Wakefield Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,801
Closed -$1.07M – 240
2025
Q4 		$1.07M Sell
8,801
-18
-0.2% -$2.26K 0.29% 112
2025
Q3 		$989K Buy
8,819
+23
+0.3% +$2.69K 0.27% 119
2025
Q2 		$1.18M Buy
+8,796
New +$966K 0.33% 97
2024
Q4 		– Sell
-6,859
Closed -$1.08M – 172
2024
Q3 		$1.08M Sell
6,859
-106
-2% -$16.3K 0.35% 79
2024
Q2 		$1.05M Buy
+6,965
New +$835K 0.37% 75

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wakefield Asset Management's TMDX Position: Q1 2026 in Review

Wakefield Asset Management sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 8,801 shares — an estimated $1.07M sold.

Wakefield Asset Management first reported a position in TMDX in Q2 2024 and held it in 5 quarters. The position peaked at $1.18M in Q2 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Wakefield Asset Management reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
  • Wakefield Asset Management sold 8,801 Transmedics shares in Q1 2026, an estimated $1.07M.
  • Wakefield Asset Management first reported a position in Transmedics in Q2 2024 and held it in 5 quarters.
  • Wakefield Asset Management's Transmedics position peaked at $1.18M in Q2 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Wakefield Asset Management's 13F filing for Q1 2026, filed 12 May 2026.